PARIS, FRANCE, 22 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Memo Therapeutics AG, a late-stage biotech company focused on p ...

Patients with continuous public insurance or frequent coverage changes face higher mortality and graft failure risk after heart transplantation.

CareDx has a transplant-testing franchise that taps into recurring surveillance demand and has deeper integration into ...

People across the United States are taking a closer look at their lettuce and leafy greens this summer thanks to an outbreak ...

Kate Markey, MBBS, PhD, FRACP , an assistant professor at Fred Hutch Cancer Center and UW Medicine, has recently been named ...

After meeting 16-year-old Eli Griffith, a heart transplant recipient, through Make-A-Wish and Fanatics, Tom Brady came away ...

The single most important question a British patient can ask a Turkish hair transplant clinic before booking is not about ...

The ADMIRE study, by treating immunocompromised patients, builds on the momentum of Alpha Tau's ReSTART pivotal trial for recurrent cSCC, which recently completed patient enrollment, under which the ...

The ADMIRE study, by treating immunocompromised patients, builds on the momentum of Alpha Tau's ReSTART pivotal trial for recurrent cSCC, which ...

Turkey has become one of the world’s most talked-about destinations for hair restoration, and Istanbul sits at the center of ...

Detailed price information for Seres Therapeutics Inc (MCRB-Q) from The Globe and Mail including charting and trades.